Publications by authors named "Robert M Swift"

Claim this Profile
P
Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.
Eric A Miller, Christy Capone, Erica Eaton, Robert M Swift, Carolina L Haass-Koffler

CNS Drugs· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial.
Carolina L Haass-Koffler, Bhavani Kashyap, Brian J Gully, Sithara S Nambiar, Rivkah Hornbacher, Robert M Swift

Contemp Clin Trials Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxytocin Reduces Noradrenergic-Induced Opioid-Like Withdrawal Symptoms in Individuals on Opioid Agonist Therapy.
Brian J Gully, Zoe E Brown, Rivkah Hornbacher, Joshua C Brown, Sudie E Back, Robert M Swift

Biol Psychiatry Glob Open Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probenecid as a pharmacotherapy for alcohol use disorder: A randomized placebo-controlled alcohol interaction trial.
Rivkah Hornbacher, Brian J Gully, Zoe E Brown, Joshua C Brown, Molly Magill, Robert M Swift

Alcohol Clin Exp Res (Hoboken)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes.
Robert M Swift

Eur J Intern Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered sleep architecture following consecutive nights of presleep alcohol.
Katie S McCullar, David H Barker, John E McGeary, Jared M Saletin, Caroline Gredvig-Ardito, Robert M Swift

Sleep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study.
Carolina L Haass-Koffler, Molly Magill, Nazzareno Cannella, Joshua C Brown, Elie G Aoun, Robert M Swift

Addict Biol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial.
Carolina L Haass-Koffler, Molly Magill, Nazzareno Cannella, Joshua C Brown, Elie G Aoun, Robert M Swift

medRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial.
Jonathan Jampel, McKenzie J Quinn, Jamie L Catalano, Chelsie B Benca-Bachman, Leslie Brick, Robert M Swift

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder.
Carolina L Haass-Koffler, Roberta Perciballi, Molly Magill, Antonella Loche, Roberto Cacciaglia, Robert M Swift

Psychopharmacology (Berl)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder.
Kimberly Goodyear, Talia R Vasaturo-Kolodner, George A Kenna, Robert M Swift, Lorenzo Leggio

Am J Drug Alcohol Abuse· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic.
Zoe E Brown, Samantha M Portis, Carline L Fleig, Talia Vasaturo-Kolodner, Robert M Swift

Alcohol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders.
Carolina L Haass-Koffler, Roberta Perciballi, Zoe E Brown, Mary R Lee, William H Zywiak, Robert M Swift

Am J Addict· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol Consumption among Samoan Adults in 2010: Patterns, Correlates and Health Implications.
Joy J Jiang, Sefuiva M Reupena, Take Naseri, Robert M Swift, John E McGeary

Alcohol Alcohol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use Disorder.
Carolina L Haass-Koffler, Daria Piacentino, Xiaobai Li, Victoria M Long, Mary R Lee, Robert M Swift

Alcohol Clin Exp Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.
Jennifer W Tidey, Suzanne M Colby, Rachel L Denlinger-Apte, Christine Goodwin, Patricia A Cioe, Robert M Swift

Nicotine Tob Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.
Carolina L Haass-Koffler, Victoria M Long, Mehdi Farokhnia, Molly Magill, George A Kenna, Robert M Swift

Neuropharmacology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Carolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, Lorenzo Leggio, George A Kenna, Robert M Swift

Alcohol Alcohol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noradrenergic targets for the treatment of alcohol use disorder.
Carolina L Haass-Koffler, Robert M Swift, Lorenzo Leggio

Psychopharmacology (Berl)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.
Carolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, Lorenzo Leggio, George A Kenna, Robert M Swift

Alcohol Alcohol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans.
Carolina L Haass-Koffler, Kimberly Goodyear, Antonella Loche, Victoria M Long, Carla Lobina, Robert M Swift

J Psychopharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters.
Carolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, Harrison H Tran, Antonella Loche, Robert M Swift

Data Brief· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers.
Carolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, Harrison H Tran, Antonella Loche, Robert M Swift

Eur J Pharm Sci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.
Carolina L Haass-Koffler, Kimberly Goodyear, William H Zywiak, Molly Magill, Sarah E Eltinge, Robert M Swift

Drug Alcohol Depend· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis